A recombinant, replication-competent vesicular stomatitis virus-based vaccine expressing a surface glycoprotein of Zaire Ebolavirus (rVSV-ZEBOV) is a promising Ebola vaccine candidate. The researchers report the results of an interim analysis of a trial of rVSV-ZEBOV in Guinea, west Africa.
UN Secretary-General Ban Ki- moon is scheduled to host an International Ebola Recovery Conference at in New York on Friday in cooperation with the presidents of Guinea, Liberia and Sierra Leone, wh
Guinea, Liberia and Sierra Leone need a further $696 million (£446.13 million) in donor funding to rebuild their battered health services over the next two years in the wake of the deadly Ebola epi
The ongoing west Africa Ebola-virus-disease epidemic has disrupted the entire health-care system in affected countries. Because of the overlap of symptoms of Ebola virus disease and malaria, the care delivery of malaria is particularly sensitive to the indirect effects of the current Ebola-virus-disease epidemic. We therefore characterise malaria case management in the context of the Ebola-virus-disease epidemic and document the effect of the Ebola-virus-disease epidemic on malaria case management.
West Africa is currently witnessing the most extensive Ebola virus (EBOV) outbreak so far recorded. Until now, there have been 27,013 reported cases and 11,134 deaths. The origin of the virus is thought to have been a zoonotic transmission from a bat to a twoyear-old boy in December 2013. From this index case the virus was spread by human-to-human contact throughout Guinea, Sierra Leone and Liberia.
Ebola-hit Guinea has extended a health emergency declared in March until the end of June, citing the persistence of the deadly virus in the country, the presidency said on Saturday.
Guinea and Sierra Leone have reported 35 new Ebola cases in the past week, four times as many as the week before, providing a reminder that the virus "will not go quietly", a top World Health Organ
